|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0034656,
umls-concept:C0040779,
umls-concept:C0333186,
umls-concept:C0444706,
umls-concept:C0450363,
umls-concept:C0936233,
umls-concept:C1456025,
umls-concept:C1522318,
umls-concept:C1696465,
umls-concept:C1708528,
umls-concept:C2348535,
umls-concept:C2603343
|
|
pubmed:issue |
20
|
|
pubmed:dateCreated |
2001-10-16
|
|
pubmed:abstractText |
Studies have reported benefit of oral therapy with the phosphodiesterase inhibitor, trapidil, in reducing restenosis after coronary angioplasty. Coronary stenting is associated with improved late outcome compared with balloon angioplasty, but significant neointimal hyperplasia still occurs in a considerable proportion of patients. The aim of this study was to investigate the safety and efficacy of trapidil 200 mg in preventing in-stent restenosis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0195-668X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2001 The European Society of Cardiology.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1938-47
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11601838-Aged,
pubmed-meshheading:11601838-Blood Vessel Prosthesis Implantation,
pubmed-meshheading:11601838-Combined Modality Therapy,
pubmed-meshheading:11601838-Coronary Angiography,
pubmed-meshheading:11601838-Coronary Artery Bypass,
pubmed-meshheading:11601838-Coronary Restenosis,
pubmed-meshheading:11601838-Coronary Vessels,
pubmed-meshheading:11601838-Endpoint Determination,
pubmed-meshheading:11601838-Female,
pubmed-meshheading:11601838-Follow-Up Studies,
pubmed-meshheading:11601838-Humans,
pubmed-meshheading:11601838-Male,
pubmed-meshheading:11601838-Middle Aged,
pubmed-meshheading:11601838-Patient Compliance,
pubmed-meshheading:11601838-Stents,
pubmed-meshheading:11601838-Trapidil,
pubmed-meshheading:11601838-Treatment Outcome,
pubmed-meshheading:11601838-Ultrasonography, Interventional,
pubmed-meshheading:11601838-Vasodilator Agents
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
The TRAPIST Study. A multicentre randomized placebo controlled clinical trial of trapidil for prevention of restenosis after coronary stenting, measured by 3-D intravascular ultrasound.
|
|
pubmed:affiliation |
Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Evaluation Studies
|
